SISCOVID - Observational, prospective, multicentre cohort of patients followed up after hospitalisation to evaluate respiratory sequelae subsequent to SARS-CoV-2 (COVID-19) infection

Head :
CALCAIANU George

Last update : 05/03/2021 | Version : 1 | ID : 73765

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Observational, prospective, multicentre cohort of patients followed up after hospitalisation to evaluate respiratory sequelae subsequent to SARS-CoV-2 (COVID-19) infection
Sign or acronym SISCOVID
General Aspects
Medical area Pneumology
Study in connection with Covid-19 Yes
Scientific investigator(s) (Contact)
Name of the director CALCAIANU
Surname George
Address Groupement Hospitalier de la Région de Mulhouse et Sud-Alsace / GHRMSA
Email george-daniel.calcaianu@ghrmsa.fr
Collaborations
Details 13 associated centers (CHR Orléans, CH Colmar, CHD La Roche Sur Yon, CH de la Côte Basque, CH Le Raincy Montfermeil, CH Douai, CHR Metz-Thionville, CH du Mans, CH Dunkerque, CH Soissons, CH Libourne, CH Annecy, CH Chambéry)
Funding
Governance of the database
Sponsor(s) or organisation(s) responsible GHRMSA health institution
Organisation status Public
Additional contact
Email marie.diesel@ghrmsa.fr
Main features
Type of database
Type of database Others
Specify eCRF
Database recruitment is carried out as part of an interventional study No
Database objective
Main objective Evaluate the respiratory sequelae after SARS-CoV-2 infection in patients hospitalised for severe COVID-19 pneumonia requiring O2, with subsequent outpatient follow-up (6 months) by:
- Low-dose chest CT scan (LD-chest CT),
- Static lung function tests (LFT),
- Arterial blood gases in ambient air at rest (AA BG) and/or with oxygen (O2 BG),
- 6-minute walking test in ambient air (6WT AA) and/or with oxygen (6WT O2)
Inclusion criteria Patient having received verbal information and not objecting to the study
Age >= 18 years inclusive
Patient hospitalised for severe COVID-19 pneumonia requiring O2
Patient having contracted SARS-CoV-2 infection proven by RT-PCR and/or retrospective serology and/or COVID-19 syndrome with chest CT scan consistent with infection (over the period from 1 March 2020 to 30 June 2020)
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered Sick population
Pathology J12 - Viral pneumonia, not elsewhere classified
Gender Male
Woman
Geography area National
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 2020
Size of the database
Size of the database (number of individuals) < 500 individuals
Data
Database activity Current data collection
Type of data collected Clinical data
Biological data
Clinical data (detail) Direct physical measures
Medical registration
Presence of a biobank No
Procedures
Followed pathology
Promotion and access
Promotion
Access

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05